These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 6732040)
1. Shortest possible acceptable effective chemotherapy in ambulatory patients with pulmonary tuberculosis. Part II. Results during the 24 months after the end of chemotherapy. Mehrotra ML; Gautam KD; Chaube CK Am Rev Respir Dis; 1984 Jun; 129(6):1016-7. PubMed ID: 6732040 [TBL] [Abstract][Full Text] [Related]
2. Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. First report. Am Rev Respir Dis; 1978 Aug; 118(2):219-28. PubMed ID: 100029 [TBL] [Abstract][Full Text] [Related]
3. A controlled trial of six months chemotherapy in pulmonary tuberculosis. Second report: results during the 24 months after the end of chemotherapy. British Thoracic Association. Am Rev Respir Dis; 1982 Sep; 126(3):460-2. PubMed ID: 6751175 [TBL] [Abstract][Full Text] [Related]
4. Shortest possible acceptable, effective ambulatory chemotherapy in pulmonary tuberculosis: preliminary report I. Mehrotra ML; Gautam KD; Chaube CK Am Rev Respir Dis; 1981 Sep; 124(3):239-44. PubMed ID: 7283256 [TBL] [Abstract][Full Text] [Related]
5. Five-year follow-up of a clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council. Am Rev Respir Dis; 1988 May; 137(5):1147-50. PubMed ID: 2904237 [TBL] [Abstract][Full Text] [Related]
6. Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis: final report. East and Central African/British Medical Research Council Fifth Collaborative Study. Tubercle; 1986 Mar; 67(1):5-15. PubMed ID: 3521015 [TBL] [Abstract][Full Text] [Related]
7. Controlled clinical trial of five short-course (4-month) chemotherapy regimens in pulmonary tuberculosis. Second report of the 4th study. East African/British Medical Research Councils Study. Am Rev Respir Dis; 1981 Feb; 123(2):165-70. PubMed ID: 7015933 [TBL] [Abstract][Full Text] [Related]
8. Controlled clinical trial of 4 short-couse regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis. Tubercle; 1983 Sep; 64(3):153-66. PubMed ID: 6356538 [TBL] [Abstract][Full Text] [Related]
9. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service/British Medical Research Council. Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):700-6. PubMed ID: 1901199 [TBL] [Abstract][Full Text] [Related]
10. Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis. Am Rev Respir Dis; 1979 Apr; 119(4):579-85. PubMed ID: 375787 [TBL] [Abstract][Full Text] [Related]
11. Clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council. Am Rev Respir Dis; 1985 Aug; 132(2):374-8. PubMed ID: 2862820 [TBL] [Abstract][Full Text] [Related]
12. [Six-months chemotherapy (2HRZS or E/4HRE) of new cases of pulmonary tuberculosis--six year experiences on its effectiveness, toxicity, and acceptability]. Wada M; Yoshiyama T; Ogata H; Ito K; Mizutani S; Sugita H Kekkaku; 1999 Apr; 74(4):353-60. PubMed ID: 10355221 [TBL] [Abstract][Full Text] [Related]
14. Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council. Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):707-12. PubMed ID: 1901200 [TBL] [Abstract][Full Text] [Related]
15. [Comparison of a 6-month chemotherapy and a l2-month chemotherapy in the treatment of pulmonary tuberculosis in Algerian Sahara. Cooperative study by an Algerian work team and the British Medical Research Council]. Chaulet P Bull Int Union Tuberc; 1985; 60(1-2):31-3. PubMed ID: 4074970 [No Abstract] [Full Text] [Related]
16. Controlled clinical trial comparing a 6-month and a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Algerian working group/British Medical Research Council cooperative study. Am Rev Respir Dis; 1984 Jun; 129(6):921-8. PubMed ID: 6375490 [TBL] [Abstract][Full Text] [Related]
17. Short-course chemotherapy for pulmonary tuberculosis. Points of interest. Zabow M; Pearson JO S Afr Med J; 1982 Jun; 61(23):867-70. PubMed ID: 7079914 [TBL] [Abstract][Full Text] [Related]
18. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis. Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119 [TBL] [Abstract][Full Text] [Related]
19. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre. Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448 [TBL] [Abstract][Full Text] [Related]
20. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]